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ABSTRACT
Objectives To systematically identify knowledge clusters 
and research gaps in the health- related preferences of 
older patients with multimorbidity by mapping current 
evidence.
Design Evidence map (systematic review variant).
Data sources MEDLINE, EMBASE, PsycINFO, PSYNDEX, 
CINAHL and Science Citation Index/Social Science Citation 
Index/-Expanded from inception to April 2018.
Study selection Studies reporting primary research 
on health- related preferences of older patients (mean 
age ≥60 years) with multimorbidity (≥2 chronic/acute 
conditions).
Data extraction Two independent reviewers assessed 
studies for eligibility, extracted data and clustered the 
studies using MAXQDA-18 content analysis software.
Results The 152 included studies (62% from North 
America, 28% from Europe) comprised 57 093 patients 
overall (range 9–9105). All used an observational design 
except for one interventional study: 63 (41%) were 
qualitative (59 cross- sectional, 4 longitudinal), 85 (57%) 
quantitative (63 cross- sectional, 22 longitudinal) and 3 (2%) 
used mixed methods. The setting was specialised care in 85 
(56%) and primary care in 54 (36%) studies. We identified 
seven clusters of studies on preferences: end- of- life care 
(n=51, 34%), self- management (n=34, 22%), treatment 
(n=32, 21%), involvement in shared decision making 
(n=25, 17%), health outcome prioritisation/goal setting 
(n=19, 13%), healthcare service (n=12, 8%) and screening/
diagnostic testing (n=1, 1%). Terminology (eg, preferences, 
views and perspectives) and concepts (eg, trade- offs, 
decision regret, goal setting) used to describe health- related 
preferences varied substantially between studies.
Conclusion Our study provides the first evidence map 
on the preferences of older patients with multimorbidity. 
Included studies were mostly conducted in developed 
countries and covered a broad range of issues. Evidence 
on patient preferences concerning decision- making on 
screening and diagnostic testing was scarce. Differences 
in employed terminology, decision- making components 
and concepts, as well as the sparsity of intervention 
studies, are challenges for future research into evidence- 
based decision support seeking to elicit the preferences of 
older patients with multimorbidity and help them construct 
preferences.
Trial registration number Open Science Framework 
(OSF): DOI 10.17605/OSF.IO/MCRWQ.
InTRODuCTIOn
Multimorbidity, defined as the co- occur-
rence of multiple medical conditions in a 
person,1 is a growing public health concern 
that affects approximately two- thirds of 
people over the age of 60 years.2 3 Patients 
with multimorbidity generally experience 
a higher burden of disease, physical disabil-
ities, adverse drug reactions, more frequent 
hospital admissions, reduced quality of life 
and increased mortality compared with those 
with a single condition.4 5 As patients face new 
and growing demands to organise and coordi-
nate their own care to comply with treatment 
regimens, multiple chronic conditions are 
often associated with high treatment burden 
in addition to the burden of the diseases 
themselves.6 If patients are overwhelmed by 
the burden, they limit their compliance to 
their preferred tasks.7 Moreover, the care of 
patients with multimorbidity is challenging, 
as treatments for one condition may adversely 
affect another.8 Robust evidence supporting 
Strengths and limitations of this study
 ► This evidence map presents a systematic overview 
of studies addressing a variety of health- related 
preferences in older patients with multimorbidity.
 ► We identified clusters of studies on, for example, 
health outcome prioritisation and end- of- life care 
preferences; few studies addressed preference- 
sensitive decisions on screening and diagnostic 
testing.
 ► The terminology and concepts used to address 
health- related preferences varied considerably in 
the included studies, highlighting a need for more 
standardisation to improve further research.
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decision- making in these patients is scarce,2 and the use 
of multiple disease- based guidelines is inappropriate, as 
they do not adequately consider potentially interacting 
conditions and treatments.9 10
The delivery of healthcare in patients with multi-
morbidity requires a patient- centred approach, that is 
‘respectful of and responsive to individual patient prefer-
ences, needs and values, and ensuring that patient values 
guide all clinical decisions’.11 The ‘Ariadne principles’12 
stress the importance of physicians and patients sharing 
realistic treatment goals, and of individualising manage-
ment and follow- up by taking patients’ preferences into 
consideration when making clinical decisions. Recent 
clinical guidelines on multimorbidity have embraced this 
approach and emphasise the incorporation of patients’ 
preferences in clinical decision- making, for example 
in the selection of appropriate self- management activi-
ties and treatment options, as well as in the prioritisa-
tion of health outcomes.13 Similarly, the consideration 
of patients’ views in the form of patient- reported expe-
riences and care outcomes have been recognised as 
critical to the achievement of high- performing health 
systems that are responsive to the needs of people with 
multimorbidity.14
It remains unclear how health- related preferences can 
be elicited from older patients with multimorbidity, as 
patients may be unfamiliar with the decision elements.15 
Moreover, concerns have been raised that patients are 
often provided with too little information about the 
benefits and harms of a treatment,16 17 may find it diffi-
cult to prioritise health outcomes and make trade- offs, 
and in consequence, may refrain from participating in 
the decision making process.18 As evidence maps allow a 
systematic approach to be used to collate evidence on a 
broad topic, we used this emerging method to map the 
health- related preferences of older patients with multi-
morbidity.19 In particular, we aimed to (1) systematically 
identify and describe key characteristics of research on 
health- related preferences of older patients with multi-
morbidity, (2) display the landscape of existing research 
in visual formats, (3) identify evidence clusters to guide 
any subsequent knowledge synthesis (systematic reviews 
and meta- analysis) and (4) identify evidence gaps and 
encourage relevant stakeholders and funding agencies to 
prioritise these in future research.
MeThODS
Reporting protocol and guideline
We described the methods in a study protocol20 that 
has since been subject to no amendments, registered 
the evidence map in Open Science Framework (OSF, 
DOI 10.17605/OSF.IO/MCRWQ) and adhered to the 
Preferred Reporting Items for Systematic Reviews and 
Meta- Analyses Extension for Scoping Reviews check-
list21 where possible (see online supplementary table 
S1).
Systematic literature search
We searched the electronic databases MEDLINE and 
EMBASE (via Wolters Kluwer’s search interface Ovid), 
PsycINFO, PSYNDEX and CINAHL (via EBSCOhost) 
and Social Science Citation Index and Science Citation 
Index Expanded (via Web of Science from Clarivate 
Analytics) from inception until April 2018. In our search, 
we combined medical subject headings with keywords 
covering old age, multimorbidity, polypharmacy and 
search terms related to patient preferences. The search 
strategy was adapted to suit the database under review 
(see online supplementary table S2 on Search strategy in 
MEDLINE—Ovid).
Based on the 32 most relevant studies identified in 
our initial search (ie, when keywords provided by the 
author contained the terms ‘multimorbidity’ and ‘patient 
preferences’ or ‘patient priorities’ and/or described a 
specific method for eliciting patients’ preferences, such 
as ‘conjoint analysis’), we conducted a cited reference 
search (forward citation tracking) using the Web of 
Science Core Collection. We also checked the reference 
lists of included studies, the reference lists of systematic 
reviews on related topics for further studies (hand search) 
and contacted the authors of conference proceedings 
that had not published a full set of results. We searched 
for ongoing trials in the Register for Clinical Trials22 and 
the WHO International Clinical Trials Registry.23
Inclusion and exclusion criteria
We included qualitative and quantitative studies involving 
older patients of 60 years and older with multimorbidity 
(two or more simultaneous chronic or acute conditions1) 
that addressed health- related patient preferences. We also 
included studies involving older patients with chronic 
conditions that are frequently associated with multimor-
bidity, even if they were not reported in detail (chronic 
heart failure, chronic obstructive pulmonary disease 
(COPD), chronic kidney disease, advanced cancer and 
frailty).24–26
We excluded studies investigating preferences relating 
to interventions of limited availability or whose legal status 
was unclear (eg, euthanasia, which is not legal or available 
in most countries), studies addressing the preferences of 
caregivers, family or medical and/or other professionals 
as well as case reports, narrative reviews and editorials. We 
did not apply any restrictions to the geographical location 
of the study or language of publication.
Study selection
Two reviewers (AIG and JN) screened the titles and 
abstracts of all references identified by electronic searches. 
Before screening, stepwise calibration was performed on 
a sample of 50 studies, with the aim of achieving 80% 
agreement between the two reviewers.20 If 80% agree-
ment had not been reached, our inclusion and exclusion 
criteria would have been refined to reach this cut- off. The 
new criteria would then have required further calibration 
using a new sample of 50 studies until the threshold was 
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reached. We also obtained full texts of potentially relevant 
articles, and two reviewers (AIG, JN or CS) independently 
assessed these for inclusion. Conflicts were resolved by 
discussion among reviewers.
Mapping the evidence
Data extraction
Following the calibration of five full text articles, two 
reviewers (AIG, JN or CS) independently extracted 
data on (1) study characteristics including study design 
(observational (qualitative, quantitative or mixed- 
methods, cross- sectional or longitudinal) and interven-
tional), geographical area, study setting (eg, primary 
care), sample size, (2) study aim, (3) patient population 
(eg, definition of multimorbidity, age, sex) and (4) char-
acteristics of preferences, such as methods used to eluci-
date patients’ preferences, and definition of preferences 
according to the authors.
Types of preference
We conducted qualitative relational content analysis27 
to derive overarching themes. The analysis was based on 
coding by two independent reviewers (AIG, JN or CS) 
using MAXQDA-18, which were further scrutinised by 
CM, JWB, MvdA, TSN and MSB.20 The initial step was 
to scrutinise title and abstract (focusing on the study 
aim) of the included studies to gain a general under-
standing of what the study was about. The full text was 
then read and re- read and codes assigned (eg, resuscita-
tion preferences28), which were later grouped according 
to overarching themes (eg, life- sustaining treatment pref-
erences).27 28 Reviewers’ categorisation of preference 
types was partly based on a previous classification (ie, 
end- of- life preferences, prioritisation of health problems, 
prioritisation of medication, preferences regarding the 
role played in decision- making, preferences in surgical 
treatment methods, prioritisation of treatment goals, 
determinants of preference, changes in preferences and 
preferences concerning the organisation of healthcare) 
obtained from a pilot study (published elsewhere) of the 
evidence map.
Mapping
We tabulated the identified studies, summarised study 
and patient characteristics, as well as study publications 
per year, and used bubble plots to display evidence clus-
ters in terms of preference type and study characteristics.
Patient and public involvement
A patient representative (KR) from the Federal Joint 
Committee ‘Gemeinsamer Bundesausschuss (G- BA)’ 
was involved in the conception and development of the 
evidence map, in the interpretation of the findings, and 
in writing the manuscript. KR has considerable expertise 
in evidence- based medicine in a healthcare context, and 
an understanding of the pivotal role of patients’ prefer-
ences in the provision of effective healthcare.
ReSulTS
literature search and selection process
Among the 9145 unique screened references, 152 studies 
(comprising over 57 000 patients) were included in 
the evidence map. As 80% agreement between the two 
reviewers was achieved in the first calibration exercise, 
inclusion and exclusion criteria remained unchanged. 
We contacted 48 authors of conference papers (13% 
answered) and included one further study that had 
already been identified in our electronic search (figure 1). 
Online supplementary tables S3a- 3f show key characteris-
tics of the included studies. Online supplementary table 
S4 presents excluded studies and reasons for exclusion.
Key characteristics of the included studies and participants
Of the included studies, all but one were observational 
(151/152), and nearly all were conducted in developed 
countries (147/152) (table 1, online supplementary tables 
S3a- S3f) and published in 2007 or thereafter (128/152) 
(see online supplementary figure S1). All studies were 
written in English.
The sample size ranged from 9 to 9105 patients and 
captured both sexes (51% female). The mean age of 
participants ranged from 60 to 85 years. Eight studies29–36 
included different age groups but only data from patients 
aged 60 years and older were included in the evidence 
map. Three studies36–38 provided no age estimate but 
were included because they clarified that they had only 
included older patients. In 87 of the included studies, 
patients with multimorbidity (no index disease defined) 
or comorbidity (index disease defined plus at least one 
other associated condition) were investigated, and in the 
remaining 65 studies, patients with conditions known to 
be highly associated with multimorbidity were included.
Types of preference and evidence clusters
Content analysis27 enabled us to identify seven major 
types of preference (table 2). We assigned 130 studies 
(85 %) to one of these types of preference and 22 (15 
%) studies37 39–57 to two types of preference. Terminology 
(eg, preferences, views and perspectives) and concepts 
(eg, trade- offs, decision regret and goal setting) varied 
substantially among studies.
End-of-life care preferences
The largest evidence cluster comprised the 51 studies 
(34 %) addressing end- of- life care preferences, most of 
which were in specialised care settings (41/51 studies) 
(figure 2). Content analysis of this preference revealed 
that advance care planning,42 in which multimorbid 
patients with advanced chronic diseases were asked how 
they would like to be cared for in the final months of their 
lives, was the main theme (table 2). The most common 
theme within this cluster concerned preferences for 
specific life- sustaining treatments (29/51),28 32–34 36 58–81 
such as cardiopulmonary resuscitation or mechanical 
ventilation. Additional topics in this cluster addressed 
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Figure 1 Evidence map Preferred Reporting Items for Systematic Reviews and Meta- Analyses flowchart.
themes such as the preferred place of death (eg, home 
vs hospice).60
Self-management preferences
The second largest evidence cluster included 34 studies 
(22 %) and addressed patients’ self- management prior-
ities, defined as activities that an individual undertakes 
to maintain or reduce the effect of a disease(s) on their 
health status.82 Most studies about self- management pref-
erences were conducted in primary care (21/34). The 
only intervention study in the evidence map (113) used 
a cluster- randomised design to evaluate whether struc-
tured priority- setting consultations led to a sustainable 
reconciliation of diverging physician–patient views on the 
importance of health problems. Overall, content anal-
ysis of this evidence cluster revealed five key themes: (1) 
patients’ prioritisation of their multiple health problems 
(20/34),30 45 47 54 83–98 as an example of which patients were 
asked how they prioritised their osteoarthritis over their 
other conditions,97 (2) patients’ preferences regarding 
self- management of their medications (8/34)42 43 47 54 99–102 
and, for instance, its association with treatment adher-
ence,42 (3) patients’ self- care behaviours (3/34)44 55 103 
aimed at accomplishing their life goals,44 (4) characteris-
tics of eHealth support tools (2/34)30 104 to help patients 
self- manage their multiple health conditions104 and (5) 
changes in patients’ choices resulting from changing 
circumstances (2/34).29 30
Treatment preferences
Thirty- two studies (22 %) investigated a variety of 
treatment preferences concerning (1) medication 
(13/32),37 41–43 47 49 53 54 105–108 perhaps for a specific 
blood pressure- lowering drug due to its characteristics 
(eg, effects and dose schedule),106 (2) dialysis as a treat-
ment option in end- stage renal disease (6/32),48 109–113 
(3) surgery (4/32),114–117 such as a decision in favour of 
implantable cardioverter- defibrillators or joint replace-
ment, (4) chemotherapy (5/32),35 57 118–120 for which 
studies may have examined preferences in adjuvant cancer 
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Table 1 Descriptive summary of included studies
Variable Total—n (%)
Study characteristics
Geographical location   
  North America 94 (62%)
  Europe 43 (28%)
  Australia and New Zealand 10 (7%)
  Asia 5 (3%)
Setting   
  Primary care 54 (36%)
  Outpatient specialised 59 (39%)
  Hospital (inpatient and emergency) 26 (17%)
  Nursing homes 5 (3%)
  Interdisciplinary 8 (5%)
Study design/method   
  Qualitative (observational) 63 (42%)
   Cross- sectional (observational) 59 (39%)
   Longitudinal (observational) 4 (6%)
  Quantitative 86 (57%)
   Cross- sectional (observational) 63 (41%)
   Longitudinal (observational) 22 (15%)
   Interventional 1 (1%)
  Mixed methods (qualitative and 
quantitative)
3 (2%)
  Observational (total) 151 (99%)
  Interventional (total) 1 (1%)
Sample size—median (range) 83 (9–9105)
  Observational   
   Qualitative 30 (9–160)
   Quantitative 196 (11–9105)
   Mixed methods 50 (32–60)
  Interventional 317
Patients’ characteristics
Type of condition   
  Studies describing multimorbid patients* 58 (38%)
  Studies describing patients with an 
index disease and comorbidity
29 (19%)
   Diabetes 7 (5%)
   Hypertension 5 (3%)
   Depression/mental illness 4 (3%)
   Cardiovascular disease 4 (3%)
   Osteoarthritis 3 (2%)
   Other 6 (4%)
  Studies describing patients with chronic 
conditions often associated with 
multimorbidity
65 (43%)
   Chronic heart failure 10 (7%)
   Advanced cancer 16 (11%)
Continued
Variable Total—n (%)
   Chronic kidney disease 15 (10%)
   COPD 4 (3%)
   Mixed (heart failure, COPD…) 20 (13%)
Age (range)† 60–85
Sex (% female)† 28 905 (51%)
*No further details of included conditions were reported in the 
majority of studies.
†Studies with overlapping population were excluded 
(n=10).36 58 59 83 84 105 109 149 161 169
COPD, chronic obstructive pulmonary disease.
Table 1 Continued
treatments and (5) non- pharmacological/conservative 
interventions (3/32),121–123 such as studies exploring 
preferences for activity interventions.121
Involvement in the shared decision making process
Twenty- five (17 %) studies explored how patients 
preferred to be involved in the shared decision making 
process. Studies in this cluster investigated preferred (1) 
patterns of engagement (21/25),37 41 46 48–52 57 124–133 (2) 
information (4/25),39 52 128 134 (3) communication with 
providers (1/25)40 and (4) patient decision aids (1/25).56
Healthcare service preferences
Twelve studies (8%) focused on preferences for certain 
healthcare services, and specifically (1) preferred care 
processes (10/12),45 135–143 such as continuity of care, 
accessibility and acceptance of the substitution of a 
physician by nurses and (2) service models (2/12),31 144 
perhaps asking patients about their preferences regarding 
Chronic Care Model recommendations.31
Health outcome prioritisation and goal setting
Nineteen studies (13%) investigated health outcome 
prioritisation and goal setting. These may have been 
(1) patients’ holistic goals for their lives or with respect 
to their various diseases (6/19),44 55 145–148 (2) health 
outcome prioritisation (10/19)53 149–157—one study in 
particular addressed the tools patients preferred to use 
to prioritise health outcomes151 and (3) collaborative 
goal setting among patients, physicians and caregivers 
(3/19).103 158 159
Screening and diagnostic tests
One study160 investigated cancer screening preferences 
among patients with multimorbidity.
DISCuSSIOn AnD COnCluSIOn
This work provides a systematic overview of research 
on health- related preferences of older patients with 
multimorbidity.
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Figure 2 Types of preference by setting and study design. Circle size represents the number of studies; pattern coding 
represents the study design. *The bubble plot displays more than the total number of included studies (n=174 vs n=152) 
because 22 studies were assigned to two different types of preference.
evidence clusters
We identified 152 studies, most of which were published 
within the last decade and conducted in developed coun-
tries. The vast majority of studies included in the evidence 
map used a qualitative or cross- sectional quantitative 
design (126/152).
Our clustering approach revealed that studies of patient 
preference focused on seven areas: end- of life care, self- 
management, treatment, involvement in shared deci-
sion making, health outcome prioritisation/goal setting, 
healthcare service delivery and screening/diagnostic 
testing. The size of the evidence clusters varied widely 
(from 1 to 51 studies) and the research objectives and 
settings differed considerably.
The largest and most homogenous cluster was of end- of- 
life preferences (51/152 studies) and was largely confined 
to specialised care (41/51). Furthermore, the study 
objectives revealed one overarching theme (advance care 
planning) and were relatively uniform compared with the 
other clusters.
Self- management and treatment preferences were the 
second (34/51) and third (32/51) largest clusters respec-
tively. Although studies about self- management pref-
erences were relatively homogeneous in terms of study 
setting (they were mostly conducted in primary care 
(21/34)), we found considerable variability in the overar-
ching themes. Treatment preferences were rather hetero-
geneous, with the cluster containing a variety of settings 
and themes.
Overall, we identified clusters of evidence. However, as 
evidence maps do not permit the critical appraisal of the 
robustness of evidence, the evidence clusters (ie, studies) 
still require verification.19
evidence gaps
Longitudinal studies were rare and the few that did 
observe changes in preference over time generally 
concerned end- of- life care preferences.33 59 63 64 66 161 The 
only intervention study we identified93 highlighted the 
fragility of prioritisation processes over time, and showed 
that health priorities shared by patients and physicians 
were often not sustainable 2 weeks after an intervention. 
Preferences tend to change when chronic conditions 
worsen,33 59 63 64 66 161 additional diagnoses are made that 
lead patients to prioritise a new condition over existing 
ones,30 or new information about treatment options is 
obtained.37 However, although crucial in clinical decision 
making, it is unclear how and why patient preferences 
change significantly over time. High quality longitudinal 
studies are needed to help physicians deal with changing 
preferences and to reassess preference- sensitive decisions.
We identified a further research gap in a lack of studies 
in older patients with multimorbidity that test the effec-
tiveness (1) of interventions using different methods to 
elicit/construct preferences, and (2) of (complex) inter-
ventions that proactively consider patient preferences 
among patient- relevant outcomes.
The smallest cluster (containing only one study) 
concerned the preferences of older patients with multi-
morbidity with respect to screening or diagnostic tests.160 
This finding is surprising, as the additional health- related 
burden of screening and diagnostic tests can be substan-
tial, and it is well- known that the risk- benefit ratio of such 
tests can be highly preference- sensitive.13
It is worthy of note that end- of- life care preferences 
were mostly assessed in specialised ambulatory care. As 
palliative care is a core task in primary care, we would 
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have expected more studies to address such end- of- life 
preferences in this setting.162
Comparison with other studies
This is the first evidence map of health- related prefer-
ences in older patients with multimorbidity. Although 
previously published evidence summaries, such as scoping 
or systematic reviews, partially addressed specific topics 
relating to some of the clusters identified in this evidence 
map, none focused on older patients with multimorbidity.
Four systematic reviews explored preferences in end- 
of- life care (as well as other preferences, such as involve-
ment in shared decision making and goal setting): (1) 
Puts et al163 164 systematically reviewed factors influencing 
older adults’ (not necessarily multimorbid) decision to 
accept or refuse cancer treatment, (2) de Decker et al165 
confirmed an association of the wish not to be resusci-
tated with multimorbidity, (3) Singh et al166 conducted a 
meta- analysis on the roles cancer patients (not necessarily 
multimorbid) prefer to play in treatment decision- making 
and (4) Vermunt et al167 evaluated studies of the effects 
of interventions that support collaborative goal setting in 
elderly people with a chronic health condition or multi-
morbidity, including our only intervention study.93
Most of the evidence summaries of health- related 
preferences focused on end- of- life care preferences, 
and specifically its determinants.163–165 Further research 
should concentrate on the clusters and gaps identified in 
our evidence map in order to enhance our understanding 
of the preferences of older patients with multimorbidity.
Strengths and limitations
A major strength of our approach is that we used a sensi-
tive strategy that combined controlled terms (ie, a defined 
vocabulary to index and retrieve information from the 
included electronic databases) and free- text searches in 
all relevant databases. Furthermore, we did not apply any 
restrictions to publication language, design or geograph-
ical location of the studies. Additionally, we searched for 
unpublished studies in registries and contacted authors 
of conference papers.
However, we addressed a broad topic with incomplete 
indexing (both, multimorbidity and patient preferences) 
and may have missed studies. In particular, we did not 
include search terms for specific measures of preference 
(eg, analytic hierarchy process, discrete choice exper-
iment and conjoint analyses) in electronic searches, 
because test searches including them did not increase 
sensitivity. Furthermore, we did not search grey literature, 
as this approach would not have identified additional 
relevant studies that could have justified the enormous 
effort involved.168
Despite the experience gathered in the pilot study 
(published elsewhere), the use of a lower age limit of at 
least 60 years was difficult to operationalise, as studies 
often included a wide age range but did not always report 
separate results for older patients. When the age group 
was unclear, we did not include the study.
Furthermore, we used an iterative process to develop 
our evidence clusters and the identified clusters and 
their definitions were agreed on by all authors. However, 
inherent to the methods used, we cannot rule out some 
subjectivity.
COnCluSIOnS AnD fuRTheR ReSeARCh OuTlOOK
This evidence map provides the first systematic overview 
of empirical investigations concerning health- related 
preferences of older patients with multimorbidity. Their 
objectives addressed a broad range of relevant topics 
across all settings and used predominantly cross- sectional 
and observational qualitative and quantitative methods. 
Our evidence map also revealed gaps, both in general – 
such as the scarcity of longitudinal studies to investigate 
changes in preferences over time, and of intervention 
studies, which, with one exception,93 failed to develop and 
test interventions to support the construction of health- 
related preferences in this population. More specifically, 
we found a remarkably low number of studies addressing 
preferences concerning end- of- life care in a primary care 
setting, as well as preferences related to screening and 
diagnostic testing. Furthermore, the included studies 
varied considerably in terms of terminology (eg, prefer-
ences, priorities, views and perceptions) and decision- 
making components and concepts (eg, trade- offs, 
decision regret and goal setting). These require further 
elucidation.
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